Entasis Therapeutics Holdings Inc.
USD2.19
-0.01 (-0.45%)
CEO
Manoussos Perros
IPO Date
2018-09-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.19
Prev. Close
$2.20
Day Low
$2.19
Day High
$2.20
| 150,000 |
| $0.00 |
| 11 Jul 2022 | Altarac David | Chief Medical Officer | J-Other | Disposed | 92,307 | $2.44 |
| 11 Jul 2022 | Altarac David | Chief Medical Officer | U-Tender | Disposed | 17,572 | $2.20 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | U-Tender | Disposed | 39,596 | $2.20 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | D-Return | Disposed | 150,000 | $0.00 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | J-Other | Disposed | 98,700 | $2.44 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | J-Other | Disposed | 50,000 | $4.94 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | J-Other | Disposed | 24,858 | $3.11 |
| 11 Jul 2022 | Tommasi Ruben | Chief Scientific Officer | J-Other | Disposed | 6,465 | $3.74 |